BlackRock’s PharmaCyte Biotech PMCB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-14
| Closed | -$18 | – | 5481 |
|
|
2025
Q1 | $18 | Buy |
+14
| New | +$18 | ﹤0.01% | 5359 |
|
|
2024
Q3 | – | Sell |
-13,346
| Closed | -$26.2K | – | 5229 |
|
|
2024
Q2 | $26.2K | Sell |
13,346
-7,758
| -37% | -$15.2K | ﹤0.01% | 4916 |
|
|
2024
Q1 | $50K | Sell |
21,104
-7,665
| -27% | -$18.2K | ﹤0.01% | 4807 |
|
|
2023
Q4 | $62.1K | Sell |
28,769
-12,944
| -31% | -$28K | ﹤0.01% | 4849 |
|
|
2023
Q3 | $87.6K | Sell |
41,713
-1,605
| -4% | -$3.37K | ﹤0.01% | 4818 |
|
|
2023
Q2 | $124K | Sell |
43,318
-393
| -0.9% | -$1.12K | ﹤0.01% | 4766 |
|
|
2023
Q1 | $127K | Buy |
43,711
+31,727
| +265% | +$92.3K | ﹤0.01% | 4818 |
|
|
2022
Q4 | $35.1K | Buy |
11,984
+836
| +7% | +$2.45K | ﹤0.01% | 5210 |
|
|
2022
Q3 | $27K | Buy |
11,148
+2,267
| +26% | +$5.49K | ﹤0.01% | 5378 |
|
|
2022
Q2 | $20K | Buy |
+8,881
| New | +$20K | ﹤0.01% | 5460 |
|